CD276 and chondrosarcoma: Additionally, in high-grade chondrosarcoma, the HDACi vorinostat upregulates B7-H3 expression on tumor cells and enhances the cytotoxic activity of B7-H3-specific CAR T-cells, demonstrating the versatility of epidrugs in amplifying immunotherapy across various cancer types [209].